V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290006831 | 290005182 | 1.55 | 45.5 | Curative (C) | 2016-10-29 | 2017-03-11 | TRASTUZUMAB | 2 | N | 290020977 | CAPECITABINE + MITOMYCIN + RT |
| 290006832 | 290005182 | 1.51 | null | Palliative (P) | 2014-09-05 | 2014-09-05 | Capecitabine + Cisplatin | 02 | N | 290020977 | TRASTUZUMAB + VINORELBINE |
| 290006833 | 290005182 | null | 54.2 | Palliative (P) | 2012-11-23 | 2013-08-23 | Carboplatin AUC 2 - 5 | null | N | 290020977 | MCX |
| 290006834 | 290005183 | 1.69 | null | null | 2014-12-24 | 2014-12-31 | Sunitinib | 02 | N | 290020983 | LANREOTIDE |
| 290006835 | 290005184 | 1.66 | 97 | Neo-adjuvant (N) | 2017-11-03 | 2017-11-04 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 290020984 | NOT MATCHED |
| 290006836 | 290005184 | 1.79 | null | Curative (C) | 2013-12-13 | 2013-12-13 | LANREOTIDE | N | N | 290020984 | CISPLATIN + RT |
| 290006837 | 290005186 | 1.76 | 67 | Palliative (P) | 2016-11-28 | 2016-12-01 | Cetuximab + Radiotherapy Maint | null | N | 290021010 | CARBOPLATIN + PACLITAXEL |
| 290006838 | 290007189 | 1.66 | 44.6 | Palliative (P) | 2018-12-11 | 2019-02-05 | NIVOLUMAB | N | Y | 290021011 | CAPECITABINE + CISPLATIN |
| 290006839 | 290007189 | 1.75 | 77.7 | Curative (C) | 2014-11-19 | 2014-12-10 | CARBOPLATIN + ETOPOSIDE | 02 | N | 290021011 | MITOMYCIN |
| 290006840 | 290005187 | 1.79 | 77.7 | Curative (C) | 2015-06-20 | 2015-06-27 | Capecitabine | N | Y | 290021015 | CARBOPLATIN + RT |
| 290006841 | 290005189 | null | null | Palliative (P) | 2018-08-25 | 2018-08-25 | EOX | Y | N | 290021019 | TRIAL |
| 290006842 | 290005191 | 1.68 | 69.2 | Palliative (P) | null | 2018-01-16 | Carboplatin AUC 6 - 10 | N | N | 290021033 | CARBO + FLUOROURACIL |
| 290006843 | 290005192 | 1.8 | null | Palliative (P) | 2017-01-25 | 2017-01-25 | Cisplatin + Radiotherapy | N | N | 290021035 | CAPECITABINE + CARBOPLATIN |
| 290006844 | 290005195 | null | 70.7 | null | 2017-12-28 | 2017-12-31 | MITOMYCIN | 02 | N | 290021036 | LANREOTIDE |
| 290006847 | 290005197 | 1.62 | null | Curative (C) | 2014-07-12 | 2014-07-27 | Capecitabine + Cisplatin | null | Y | 290021043 | CARBOPLATIN + RT |
| 290006848 | 290005197 | 1.68 | 39.2 | Palliative (P) | null | 2016-09-04 | Carboplatin + Cetux + FU (Cycle 1) | 02 | N | 290021043 | CARBOPLATIN + CETUXIMAB + FU |
| 290006849 | 290005198 | 1.68 | 56.9 | Neo-adjuvant (N) | 2017-04-11 | 2017-04-11 | CETUXIMAB | Y | N | 290021050 | CISPLATIN + FLUOROURACIL + RT |
| 290006850 | 290005200 | 1.9 | null | Palliative (P) | null | 2015-02-09 | Trial Unspecified | null | N | 290021051 | CRIZOTINIB |
| 290006851 | 290005201 | 1.66 | null | Palliative (P) | 2016-11-17 | 2016-11-17 | CARBOPLATIN + RT | 99 | null | 290021057 | OXALIPLATIN + MDG + PANITUMUMAB |
| 290006852 | 290007195 | 1.52 | 54.1 | Palliative (P) | null | 2015-06-17 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 290021064 | CAPECITABINE + IRINOTECAN |
| 290006853 | 290007195 | 1.71 | 92.5 | Palliative (P) | 2016-08-03 | 2016-09-03 | Sunitinib | Y | N | 290021064 | EVEROLIMUS |
| 290006854 | 290005202 | 1.52 | 59.2 | null | 2015-05-30 | 2015-06-12 | CARBOPLATIN + RT | N | null | 290021080 | LANREOTIDE |
| 290006855 | 290007196 | 1.54 | null | Curative (C) | 2018-02-06 | 2018-02-23 | Cisplatin 100 + RT(H&N) 1 day | 02 | null | 290021087 | CARBOPLATIN + RT |
| 290006856 | 290007994 | null | null | Palliative (P) | 2013-07-07 | 2013-12-16 | Cisplatin 7 day | 2 | Y | 290021092 | OCTREOTIDE |
| 290006857 | 290005203 | 1.51 | 86 | Palliative (P) | 2017-06-27 | 2017-08-05 | CAPECITABINE + OXALIPLATIN | N | N | 290021099 | CARBO + FLUOROURACIL |
| 290006858 | 290005204 | 1.6 | null | Palliative (P) | 2014-08-02 | 2014-11-19 | Capecitabine + Oxaliplatin 21day | 2 | N | 290021101 | ETOPOSIDE |
| 290006859 | 290005205 | 1.56 | null | Palliative (P) | 2018-03-29 | 2018-03-29 | Trial Unspecified | 2 | N | 290021101 | TRASTUZUMAB + VINORELBINE |
| 290006860 | 290005206 | 1.73 | 48 | Disease modification (D) | 2013-06-25 | 2013-07-08 | INTERAACT trial | 02 | N | 290021110 | CYCLOPHOSPHAMIDE + LENALIDOMIDE |
| 290006861 | 290005207 | null | 65.55 | Palliative (P) | 2015-07-27 | 2015-07-28 | Capecitabine 35days + RT | N | null | 290021110 | CAPECITABINE + CISPLATIN |
| 290006862 | 290005208 | null | 50.4 | Palliative (P) | 2017-05-18 | 2017-05-18 | CARBOPLATIN + RT | N | N | 290021130 | CAPECITABINE |
| 290006863 | 290005208 | 1.75 | 74.8 | Palliative (P) | 2015-06-04 | 2015-06-30 | Capecitabine + Oxaliplatin 21day | N | Y | 290021130 | TRASTUZUMAB + VINORELBINE |
| 290006864 | 290007997 | 1.72 | 78.7 | Palliative (P) | 2016-04-23 | 2016-05-08 | Capecitabine | 02 | N | 290021136 | SUNITINIB |
| 290006865 | 290005209 | 1.48 | null | Palliative (P) | 2014-12-14 | 2014-12-14 | INTERAACT trial | 02 | N | 290021146 | CAPECITABINE |
| 290006866 | 290005210 | 1.78 | 74.9 | null | 2017-06-03 | 2017-06-18 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 290021152 | LANREOTIDE |
| 290006867 | 290005211 | 0 | 49.7 | Palliative (P) | null | 2015-11-21 | CETUXIMAB | N | N | 290021153 | PEMBROLIZUMAB |
| 290006868 | 290005212 | null | null | Palliative (P) | 2017-08-24 | 2017-08-31 | Carboplatin + Paclitaxel (weekly) | 02 | null | 290021156 | CARBOPLATIN |
| 290006869 | 290005212 | 1.67 | null | Curative (C) | 2013-07-23 | 2013-07-29 | LANREOTIDE | 02 | null | 290021156 | BALLAD TRIAL |
| 290006870 | 290005213 | 1.54 | 76.3 | Palliative (P) | 2017-09-27 | 2017-10-14 | FEC 100 | 02 | N | 290021161 | Y-90 |
| 290006871 | 290005214 | 1.67 | 84.4 | Neo-adjuvant (N) | 2017-11-16 | 2017-12-02 | MITOMYCIN | N | N | 290021171 | CISPLATIN + RT |
| 290006872 | 290005216 | 1.68 | 78.7 | Palliative (P) | 2014-08-17 | 2014-10-01 | Capecitabine + Cisplatin | N | N | 290021172 | CAPECITABINE + OXALIPLATIN |
| 290006873 | 290005219 | 1.58 | 75.6 | Palliative (P) | 2013-12-06 | 2013-12-12 | Ipilimumab | 02 | null | 290021174 | CAPECITABINE |
| 290006874 | 290005220 | 1.68 | 62.4 | Curative (C) | 2017-10-12 | 2017-10-18 | Paclitaxel 7 day | N | N | 290021177 | CISPLATIN |
| 290006875 | 290005223 | null | 62 | Palliative (P) | 2014-08-01 | 2014-08-01 | Cetuximab + Radiotherapy Load | N | Y | 290021181 | CARBO + FLUOROURACIL |
| 290006876 | 290005224 | 1.64 | 56.4 | Adjuvant (A) | 2014-11-19 | 2014-12-28 | Cetuximab 7 day (>Cycle 2) | N | N | 290021181 | CAPECITABINE + CARBOPLATIN |
| 290006877 | 290007998 | 1.68 | null | Palliative (P) | 2018-05-18 | 2018-06-19 | CISPLATIN + FLUOROURACIL + RT | N | N | 290021194 | CAPECITABINE |
| 290006878 | 290007998 | null | null | Curative (C) | 2012-11-29 | 2014-01-28 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | 290021194 | CISPLATIN + RT |
| 290006880 | 290005226 | 1.9 | null | Curative (C) | 2015-06-28 | 2015-07-17 | Carboplatin AUC 6 - 10 | N | N | 290021207 | CAPECITABINE + OXALIPLATIN |
| 290006881 | 290005228 | 1.59 | 76 | Curative (C) | 2014-06-23 | 2014-12-10 | Docetaxel 75mg/m2 (21 day) | N | null | 290021208 | BRENTUXIMAB |
| 290006882 | 290005229 | 1.67 | null | Curative (C) | 2017-02-20 | 2017-02-25 | Trastuzumab Subcutaneous | 2 | Y | 290021210 | MITOMYCIN |
| 290006883 | 290005229 | 1.78 | 107.25 | null | 2013-12-30 | 2014-01-16 | Capecitabine | N | null | 290021210 | CHOP |